Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 66-22-8
2. 2,4-dihydroxypyrimidine
3. 2,4(1h,3h)-pyrimidinedione
4. 2,4-pyrimidinediol
5. Pyrimidine-2,4(1h,3h)-dione
6. 2,4-dioxopyrimidine
7. Pyrod
8. Pyrimidine-2,4-diol
9. Hybar X
10. 2,4-pyrimidinedione
11. Pirod
12. 1h-pyrimidine-2,4-dione
13. 51953-14-1
14. Uracil [usan]
15. Ru 12709
16. Ura
17. Mfcd00006016
18. Ccris 3077
19. Uracyl
20. Urazil
21. 2-hydroxy-4(3h)-pyrimidinone
22. Sq 6201
23. Sq 7726
24. Sq 8493
25. Chebi:17568
26. 1,2,3,4-tetrahydropyrimidine-2,4-dione
27. Bms 205603-01
28. Ai3-25470
29. Nsc 3970
30. Nsc-3970
31. Sq-6201
32. Sq-7726
33. Sq-8493
34. Lamivudine Impurity E
35. 2-hydroxy-4(1h)-pyrimidinone
36. Bms-205603-01
37. Lamivudine Impurity E Rs
38. 144104-68-7
39. 66255-05-8
40. 56hh86zvct
41. 4-hydroxy-2(1h)-pyrimidinone
42. Fluorouracil Specified Compound C
43. Nsc3970
44. Ncgc00181030-01
45. Dsstox_cid_1424
46. Dsstox_rid_76153
47. Dsstox_gsid_21424
48. 4-hydroxyuracil
49. Cas-66-22-8
50. Cid 5274267
51. Uracil (8ci)
52. Uracil [usan:jan]
53. Einecs 200-621-9
54. Unii-56hh86zvct
55. 2,4-pyrimidinediol (9ci)
56. 4(3h)-pyrimidinone, 2-hydroxy- (9ci)
57. 8h-uracil
58. Hydroxypyrimidinone
59. 2,6-dioxypyrimidin
60. Uracil,(s)
61. 2,4-dioxypyrimidine
62. 2,4(1h,3h)-pyrimidinedione (9ci)
63. Pyrimidine-2,4-dione
64. Fluorouracil Impurity C
65. Uracil, 99%
66. 1ui0
67. Uracil (jan/usan)
68. 2,3h)-pyrimidinedione
69. 2,6-dihydroxypyrimidine
70. Uracil [inci]
71. Uracil [jan]
72. Uracil [usp-rs]
73. Uracil [who-dd]
74. Uracil [mi]
75. Uracil [mart.]
76. Bmse000187
77. Bmse000940
78. Chembl566
79. Epitope Id:120356
80. Ncimech_000782
81. Schembl8235
82. Uracil, >=99.0%
83. Mls001304993
84. Gtpl4560
85. 2,4-(1h,3h)-pyrimidinedione
86. Dtxsid4021424
87. 1h-pyrimidine-2,4-dione;uracil
88. Uracil, >=99.0% (t)
89. Hms2234e19
90. Hms3264c13
91. Hms3373e18
92. Hms3652n05
93. Pharmakon1600-01502345
94. Zinc895045
95. Bcp26546
96. Hy-i0960
97. Nsc29742
98. Tox21_112680
99. Tox21_201023
100. Bdbm50549809
101. Ccg-35866
102. Nsc-29742
103. Nsc759649
104. S4177
105. Stk301734
106. Stl124066
107. Akos000119989
108. Akos002303991
109. Tox21_112680_1
110. 4(3h)-pyrimidinone,2-hydroxy-(9ci)
111. Am83913
112. Ccg-213042
113. Cs-w020104
114. Db03419
115. Nsc-759649
116. Ps-5279
117. Sb55489
118. Sb55884
119. Ncgc00181030-02
120. Ncgc00247663-01
121. Ncgc00258576-01
122. Uracil, Vetec(tm) Reagent Grade, 98%
123. Nci60_003718
124. Pyrimidine-2,4(1h,3h)-dione (uracil)
125. Smr000752912
126. Sy008943
127. Uracil 1000 Microg/ml In Methanol:water
128. Db-030518
129. Db-103964
130. Lamivudine Impurity F [ep Impurity]
131. Bb 0242167
132. Fluorouracil Impurity C [ep Impurity]
133. Ft-0609769
134. Ft-0694063
135. Ft-0695907
136. Ft-0695908
137. Ft-0773727
138. Lamivudine Impurity E [usp Impurity]
139. Sw220239-1
140. U0013
141. Uracil, Suitable For Cell Culture, Bioreagent
142. C00106
143. D00027
144. Ab00171810_03
145. Ab00171810_04
146. Ab00918623-05
147. A835376
148. Ac-907/30002021
149. Q182990
150. Z56889474
151. F1796-0008
152. Fluorouracil Specified Compound C [usp Impurity]
153. E2fc11e5-1887-46df-b415-82313ce9b2bd
154. Uracil, United States Pharmacopeia (usp) Reference Standard
155. Fluorouracil Impurity C, European Pharmacopoeia (ep) Reference Standard
156. Uracil, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 112.09 g/mol |
|---|---|
| Molecular Formula | C4H4N2O2 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 112.027277375 g/mol |
| Monoisotopic Mass | 112.027277375 g/mol |
| Topological Polar Surface Area | 58.2 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 161 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
28
PharmaCompass offers a list of Uracil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Uracil manufacturer or Uracil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Uracil manufacturer or Uracil supplier.
PharmaCompass also assists you with knowing the Uracil API Price utilized in the formulation of products. Uracil API Price is not always fixed or binding as the Uracil Price is obtained through a variety of data sources. The Uracil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-66-22-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-66-22-8, including repackagers and relabelers. The FDA regulates CAS-66-22-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-66-22-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-66-22-8 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-66-22-8 supplier is an individual or a company that provides CAS-66-22-8 active pharmaceutical ingredient (API) or CAS-66-22-8 finished formulations upon request. The CAS-66-22-8 suppliers may include CAS-66-22-8 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-66-22-8 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
CAS-66-22-8 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-66-22-8 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-66-22-8 GMP manufacturer or CAS-66-22-8 GMP API supplier for your needs.
A CAS-66-22-8 CoA (Certificate of Analysis) is a formal document that attests to CAS-66-22-8's compliance with CAS-66-22-8 specifications and serves as a tool for batch-level quality control.
CAS-66-22-8 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-66-22-8 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-66-22-8 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-66-22-8 EP), CAS-66-22-8 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-66-22-8 USP).
